Foundayo to Be Removed From the Texas Medicaid Formulary Effective October 30, 2026
Act
by Oct 30, 2026
Effective date
Oct 30, 2026
Identified
Oct 24, 2026
Summary
Texas Medicaid (HHSC Vendor Drug Program) is removing Foundayo from the formulary effective October 30, 2026, due to erroneous addition on September 20, 2026. All NDCs for Foundayo tablets (0.8 mg through 17.2 mg) will lose provisional coverage status, making the drug non-covered for Texas Medicaid beneficiaries.
Get alerts when payers change rules like this one
We check Texas Medicaid and other payers every day and email you when a change matches your specialty and state.
01Billing team must update pharmacy systems and prior authorization workflows to reflect that all Foundayo NDCs (00002417801, 00002417831, 00002450301, 00002450331, 00002479401, 00002479431, 00002480301, 00002480331, 00002483901, 00002483931, 00002495301, 00002495331) are no longer covered under Texas Medicaid.
02Review any pending or standing prescriptions for Texas Medicaid patients and communicate delisting to prescribers and the dispensing pharmacy.
03Claims submitted after October 30, 2026, for these NDCs will be denied as non-formulary.
04Contact vdp-formulary@hhsc.state.tx.us with questions regarding the removal.
Original notice
Foundayo to Be Removed From the Texas Medicaid Formulary Effective October 30, 2026
tmhp.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.